<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37457560</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Exploring potential biomarkers and therapeutic targets of long COVID-associated inflammatory cardiomyopathy.</ArticleTitle><Pagination><StartPage>1191354</StartPage><MedlinePgn>1191354</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1191354</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2023.1191354</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The negative impact of long COVID on social life and human health is increasingly prominent, and the elevated risk of cardiovascular disease in patients recovering from COVID-19 has also been fully confirmed. However, the pathogenesis of long COVID-related inflammatory cardiomyopathy is still unclear. Here, we explore potential biomarkers and therapeutic targets of long COVID-associated inflammatory cardiomyopathy.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Datasets that met the study requirements were identified in Gene Expression Omnibus (GEO), and differentially expressed genes (DEGs) were obtained by the algorithm. Then, functional enrichment analysis was performed to explore the basic molecular mechanisms and biological processes associated with DEGs. A protein-protein interaction (PPI) network was constructed and analyzed to identify hub genes among the common DEGs. Finally, a third dataset was introduced for validation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Ultimately, 3,098 upregulated DEGs and 1965 downregulated DEGs were extracted from the inflammatory cardiomyopathy dataset. A total of 89 upregulated DEGs and 217 downregulated DEGs were extracted from the dataset of convalescent COVID patients. Enrichment analysis and construction of the PPI network confirmed VEGFA, FOXO1, CXCR4, and SMAD4 as upregulated hub genes and KRAS and TXN as downregulated hub genes. The separate dataset of patients with COVID-19 infection used for verification led to speculation that long COVID-associated inflammatory cardiomyopathy is mainly attributable to the immune-mediated response and inflammation rather than to direct infection of cells by the virus.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Screening of potential biomarkers and therapeutic targets sheds new light on the pathogenesis of long COVID-associated inflammatory cardiomyopathy as well as potential therapeutic approaches. Further clinical studies are needed to explore these possibilities in light of the increasingly severe negative impacts of long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Qi, Huang and Zhu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Emergency, First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Mengjie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Haiyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency, First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">bioinformatic analysis</Keyword><Keyword MajorTopicYN="N">differentially expressed genes</Keyword><Keyword MajorTopicYN="N">inflammatory cardiomyopathy</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>4</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37457560</ArticleId><ArticleId IdType="pmc">PMC10346863</ArticleId><ArticleId IdType="doi">10.3389/fmed.2023.1191354</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Burden of Disease 2020 Health Financing Collaborator Network . Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050. Lancet. (2021) 398:1317&#x2013;43. doi: 10.1016/S0140-6736(21)01258-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01258-7</ArticleId><ArticleId IdType="pmc">PMC8457757</ArticleId><ArticleId IdType="pubmed">34562388</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal A, Erondu NA, Heymann DL, Gitahi G, Yates R. Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage. Lancet. (2021) 397:61&#x2013;7. doi: 10.1016/S0140-6736(20)32228-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32228-5</ArticleId><ArticleId IdType="pmc">PMC7834479</ArticleId><ArticleId IdType="pubmed">33275906</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. (2022) 28:1461&#x2013;7. doi: 10.1038/s41591-022-01840-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. (2022) 400:452&#x2013;61. doi: 10.1016/S0140-6736(22)01214-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature reviews. Microbiology. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. (2021) 93:2555&#x2013;6. doi: 10.1002/jmv.26624, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. doi: 10.1016/j.eclinm.2021.101019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. (2021) 9:927&#x2013;37. doi: 10.1016/j.jchf.2021.10.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. (2022) 10:311&#x2013;21. doi: 10.1016/S2213-8587(22)00044-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28:583&#x2013;90. doi: 10.1038/s41591-022-01689-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. . Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin Infect Dis. (2023) 76:e487&#x2013;90. doi: 10.1093/cid/ciac722</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that May contribute to persistent symptoms. Front Microbiol. (2021) 12:698169. doi: 10.3389/fmicb.2021.698169, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Invest Med. (2022) 70:61&#x2013;7. doi: 10.1136/jim-2021-002051, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. (2022) 23:210&#x2013;6. doi: 10.1038/s41590-021-01113-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cells. (2022) 185:881&#x2013;95.e20. doi: 10.1016/j.cell.2022.01.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, et al. . Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). J Transl Med. (2022) 20:138. doi: 10.1186/s12967-022-03346-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, et al. . Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med. (2021) 8:745758. doi: 10.3389/fcvm.2021.745758, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al. . Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID/post-acute sequelae of COVID-19 (PASC). Cardiovasc Diabetol. (2022) 21:148. doi: 10.1186/s12933-022-01579-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma&#x142;ek &#x141;A, Marczak M, Mi&#x142;osz-Wieczorek B, Konopka M, Braksator W, Drygas W, et al. . Cardiac involvement in consecutive elite athletes recovered from Covid-19: a magnetic resonance study. J Magn Reson Imaging. (2021) 53:1723&#x2013;9. doi: 10.1002/jmri.27513, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.27513</ArticleId><ArticleId IdType="pmc">PMC8014772</ArticleId><ArticleId IdType="pubmed">33474768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP, et al. . Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. (2021) 6:116&#x2013;8. doi: 10.1001/jamacardio.2020.4916, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.4916</ArticleId><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, et al. . Recognition and initial Management of Fulminant Myocarditis: a scientific statement from the American Heart Association. Circulation. (2020) 141:e69&#x2013;92. doi: 10.1161/CIR.0000000000000745, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000745</ArticleId><ArticleId IdType="pubmed">31902242</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res. (2001) 50:399&#x2013;408. doi: 10.1016/S0008-6363(01)00254-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-6363(01)00254-1</ArticleId><ArticleId IdType="pubmed">11334844</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsch&#xf6;pe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. . Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. (2021) 18:169&#x2013;93. doi: 10.1038/s41569-020-00435-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00435-x</ArticleId><ArticleId IdType="pmc">PMC7548534</ArticleId><ArticleId IdType="pubmed">33046850</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. . Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:1265&#x2013;73. doi: 10.1001/jamacardio.2020.3557, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs A, Vassall A. Count the cost of disability caused by COVID-19. Nature. (2021) 593:502&#x2013;5. doi: 10.1038/d41586-021-01392-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01392-2</ArticleId><ArticleId IdType="pubmed">34040204</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. The road to addressing long Covid. Science (New York, NY). (2021) 373:491&#x2013;3. doi: 10.1126/science.abg7113</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg7113</ArticleId><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. (2004) 20:307&#x2013;15. doi: 10.1093/bioinformatics/btg405, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btg405</ArticleId><ArticleId IdType="pubmed">14960456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. . Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. (2015) 43:e47. doi: 10.1093/nar/gkv007, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar R, Leimanis ML, Newbury PA, Liu K, Xing J, Nedveck D, et al. . Gene expression signatures identify paediatric patients with multiple organ dysfunction who require advanced life support in the intensive care unit. EBioMedicine. (2020) 62:103122. doi: 10.1016/j.ebiom.2020.103122, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103122</ArticleId><ArticleId IdType="pmc">PMC7704404</ArticleId><ArticleId IdType="pubmed">33248372</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. . Gene ontology: tool for the unification of biology. Gene Ontol Consort Nat Genet. (2000) 25:25&#x2013;9. doi: 10.1038/75556, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/75556</ArticleId><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Altermann E, Klaenhammer TR. PathwayVoyager: pathway mapping using the Kyoto encyclopedia of genes and genomes (KEGG) database. BMC Genomics. (2005) 6:60. doi: 10.1186/1471-2164-6-60, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-6-60</ArticleId><ArticleId IdType="pmc">PMC1112592</ArticleId><ArticleId IdType="pubmed">15869710</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. (2012) 16:284&#x2013;7. doi: 10.1089/omi.2011.0118, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter W, S&#xe1;nchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. (2015) 31:2912&#x2013;4. doi: 10.1093/bioinformatics/btv300, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv300</ArticleId><ArticleId IdType="pubmed">25964631</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. . The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. (2021) 49:D605&#x2013;12. doi: 10.1093/nar/gkaa1074, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1074</ArticleId><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. (2003) 13:2498&#x2013;504. doi: 10.1101/gr.1239303, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. (2014) 8:S11. doi: 10.1186/1752-0509-8-S4-S11</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-8-S4-S11</ArticleId><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlen M, Karlsson MJ, Zhong W, Tebani A, Pou C, Mikes J, et al. . A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science (New York, NY). (2019) 366:eaax9198. doi: 10.1126/science.aax9198</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax9198</ArticleId><ArticleId IdType="pubmed">31857451</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi H, Muruganujan A, Huang X, Ebert D, Mills C, Guo X, et al. . Protocol update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat Protoc. (2019) 14:703&#x2013;21. doi: 10.1038/s41596-019-0128-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-019-0128-8</ArticleId><ArticleId IdType="pmc">PMC6519457</ArticleId><ArticleId IdType="pubmed">30804569</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. . Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. (2023) 76:e487&#x2013;90. doi: 10.1093/cid/ciac722, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, et al. . Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. (2021) 70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC, Ng SSS, et al. . Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. (2022) 71:544&#x2013;52. doi: 10.1136/gutjnl-2021-325989, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science (New York, NY). (2022) 375:267&#x2013;9. doi: 10.1126/science.abm2052</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavileci B, &#xd6;zdemir E, &#xd6;zdemir B, Ereren E, Cengiz M. De-novo development of fragmented QRS during a six-month follow-up period in patients with COVID-19 disease and its cardiac effects. J Electrocardiol. (2022) 72:44&#x2013;8. doi: 10.1016/j.jelectrocard.2022.02.012, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2022.02.012</ArticleId><ArticleId IdType="pmc">PMC8917010</ArticleId><ArticleId IdType="pubmed">35306293</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist JT, Collier GJ, Walters H, Kim M, Chen M, Abu Eid G, et al. . Lung abnormalities detected with hyperpolarized (129)Xe MRI in patients with long COVID. Radiology. (2022) 305:709&#x2013;17. doi: 10.1148/radiol.220069, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220069</ArticleId><ArticleId IdType="pmc">PMC9134268</ArticleId><ArticleId IdType="pubmed">35608443</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M, Vig&#xf3;n L, Fuertes D, Murciano-Ant&#xf3;n MA, Casado-Fern&#xe1;ndez G, Dom&#xed;nguez-Mateos S, et al. . Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with long-COVID: identification of diagnostic biomarkers. Front Immunol. (2022) 13:848886. doi: 10.3389/fimmu.2022.848886, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG, Mustapic M, Kapogiannis D, Henrich TJ, Lu S, et al. . SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann Neurol. (2022) 91:772&#x2013;81. doi: 10.1002/ana.26350, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. (2020) 100:327&#x2013;32. doi: 10.1016/j.ijid.2020.09.016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez CJ. Post-COVID-19 syndrome (PC19S): chronic reactive Endotheliitis and disseminated vascular disease. Acta Med Port. (2020) 33:859. doi: 10.20344/amp.14612, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.20344/amp.14612</ArticleId><ArticleId IdType="pubmed">33496258</ArticleId></ArticleIdList></Reference><Reference><Citation>Braile M, Marcella S, Cristinziano L, Galdiero MR, Modestino L, Ferrara AL, et al. . VEGF-A in cardiomyocytes and heart diseases. Int J Mol Sci. (2020) 21:5294. doi: 10.3390/ijms21155294, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155294</ArticleId><ArticleId IdType="pmc">PMC7432634</ArticleId><ArticleId IdType="pubmed">32722551</ArticleId></ArticleIdList></Reference><Reference><Citation>Taimeh Z, Loughran J, Birks EJ, Bolli R. Vascular endothelial growth factor in heart failure. Nat Rev Cardiol. (2013) 10:519&#x2013;30. doi: 10.1038/nrcardio.2013.94</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2013.94</ArticleId><ArticleId IdType="pubmed">23856679</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J, Wang J, Kong X, Yang J, Guo L, Zheng F, et al. . Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway. Exp Cell Res. (2009) 315:3521&#x2013;31. doi: 10.1016/j.yexcr.2009.09.026, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2009.09.026</ArticleId><ArticleId IdType="pubmed">19800880</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z, Chen B, Tan X, Zhao Y, Wang L, Zhu T, et al. . Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci U S A. (2011) 108:2064&#x2013;9. doi: 10.1073/pnas.1018925108, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1018925108</ArticleId><ArticleId IdType="pmc">PMC3033313</ArticleId><ArticleId IdType="pubmed">21245320</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res. (2001) 49:507&#x2013;21. doi: 10.1016/S0008-6363(00)00281-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-6363(00)00281-9</ArticleId><ArticleId IdType="pubmed">11166264</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgers M, Voipio-Pulkki L, Izumo S. Apoptosis. Cardiovasc Res. (2000) 45:525&#x2013;7. doi: 10.1016/S0008-6363(99)00404-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-6363(99)00404-6</ArticleId><ArticleId IdType="pubmed">11274981</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T, Zhao W, Chen Y, Liu L, Ahokas RA, Sun Y. Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart. Int J Cardiol. (2013) 167:2638&#x2013;45. doi: 10.1016/j.ijcard.2012.06.127, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2012.06.127</ArticleId><ArticleId IdType="pmc">PMC3714340</ArticleId><ArticleId IdType="pubmed">22818386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandula V, Kosuru R, Li H, Yan D, Zhu Q, Lian Q, et al. . Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy. Cardiovasc Diabetol. (2016) 15:44. doi: 10.1186/s12933-016-0361-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-016-0361-1</ArticleId><ArticleId IdType="pmc">PMC4784400</ArticleId><ArticleId IdType="pubmed">26956801</ArticleId></ArticleIdList></Reference><Reference><Citation>Murtaza G, Khan AK, Rashid R, Muneer S, Hasan SMF, Chen J. FOXO transcriptional factors and long-term living. Oxidative Med Cell Longev. (2017) 2017:1&#x2013;8. doi: 10.1155/2017/3494289</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/3494289</ArticleId><ArticleId IdType="pmc">PMC5574317</ArticleId><ArticleId IdType="pubmed">28894507</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Xia P, Huang G, Zhu P, Liu J, Ye B, et al. . FoxO1-mediated autophagy is required for NK cell development and innate immunity. Nat Commun. (2016) 7:11023. doi: 10.1038/ncomms11023, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11023</ArticleId><ArticleId IdType="pmc">PMC4820827</ArticleId><ArticleId IdType="pubmed">27010363</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing YQ, Li A, Yang Y, Li XX, Zhang LN, Guo HC. The regulation of FOXO1 and its role in disease progression. Life Sci. (2018) 193:124&#x2013;31. doi: 10.1016/j.lfs.2017.11.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2017.11.030</ArticleId><ArticleId IdType="pubmed">29158051</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton C, Poznansky MC, Reeves P. Polyfunctionality of the CXCR4/CXCL12 axis in health and disease: implications for therapeutic interventions in cancer and immune-mediated diseases. FASEB J. (2021) 35:e21260. doi: 10.1096/fj.202001273R, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001273R</ArticleId><ArticleId IdType="pubmed">33715207</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;ring Y, Pawig L, Weber C, Noels H. The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease. Front Physiol. (2014) 5:212. doi: 10.3389/fphys.2014.00212</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00212</ArticleId><ArticleId IdType="pmc">PMC4052746</ArticleId><ArticleId IdType="pubmed">24966838</ArticleId></ArticleIdList></Reference><Reference><Citation>Debnath B, Xu S, Grande F, Garofalo A, Neamati N. Small molecule inhibitors of CXCR4. Theranostics. (2013) 3:47&#x2013;75. doi: 10.7150/thno.5376, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.5376</ArticleId><ArticleId IdType="pmc">PMC3563081</ArticleId><ArticleId IdType="pubmed">23382786</ArticleId></ArticleIdList></Reference><Reference><Citation>Isles HM, Herman KD, Robertson AL, Loynes CA, Prince LR, Elks PM, et al. . The CXCL12/CXCR4 signaling Axis retains neutrophils at inflammatory sites in zebrafish. Front Immunol. (2019) 10:1784. doi: 10.3389/fimmu.2019.01784, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01784</ArticleId><ArticleId IdType="pmc">PMC6684839</ArticleId><ArticleId IdType="pubmed">31417560</ArticleId></ArticleIdList></Reference><Reference><Citation>De Ceuninck F, Duguet F, Aussy A, Laigle L, Moingeon P. IFN-&#x3b1;: a key therapeutic target for multiple autoimmune rheumatic diseases. Drug Discov Today. (2021) 26:2465&#x2013;73. doi: 10.1016/j.drudis.2021.06.010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2021.06.010</ArticleId><ArticleId IdType="pubmed">34224903</ArticleId></ArticleIdList></Reference><Reference><Citation>McHugh J. Hitting the right spot on CXCR4. Nat Rev Rheumatol. (2019) 15:514. doi: 10.1038/s41584-019-0287-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-019-0287-6</ArticleId><ArticleId IdType="pubmed">31371800</ArticleId></ArticleIdList></Reference><Reference><Citation>Adlere I, Caspar B, Arimont M, Dekkers S, Visser K, Stuijt J, et al. . Modulators of CXCR4 and CXCR7/ACKR3 function. Mol Pharmacol. (2019) 96:737&#x2013;52. doi: 10.1124/mol.119.117663, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.119.117663</ArticleId><ArticleId IdType="pubmed">31548340</ArticleId></ArticleIdList></Reference><Reference><Citation>De Clercq E. Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100. Mini Rev Med Chem. (2005) 5:805&#x2013;24. doi: 10.2174/1389557054867075, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389557054867075</ArticleId><ArticleId IdType="pubmed">16178723</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Mishra L, Deng CX. The role of TGF-&#x3b2;/SMAD4 signaling in cancer. Int J Biol Sci. (2018) 14:111&#x2013;23. doi: 10.7150/ijbs.23230, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.23230</ArticleId><ArticleId IdType="pmc">PMC5821033</ArticleId><ArticleId IdType="pubmed">29483830</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Hou S, Chen J, Zhang J, Lin F, Ju R, et al. . Smad4 deficiency in smooth muscle cells initiates the formation of aortic aneurysm. Circ Res. (2016) 118:388&#x2013;99. doi: 10.1161/CIRCRESAHA.115.308040, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.308040</ArticleId><ArticleId IdType="pubmed">26699655</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Wang J, Zeng Z, Qiao L, Zhuang L, Jiang L, et al. . Smad4 is required for the development of cardiac and skeletal muscle in zebrafish. Differentiation. (2016) 92:161&#x2013;8. doi: 10.1016/j.diff.2016.06.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diff.2016.06.005</ArticleId><ArticleId IdType="pubmed">27477184</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Guo Z, Wang F, Fu L. KRAS mutation: from undruggable to druggable in cancer. Signal Transduct Target Ther. (2021) 6:386. doi: 10.1038/s41392-021-00780-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00780-4</ArticleId><ArticleId IdType="pmc">PMC8591115</ArticleId><ArticleId IdType="pubmed">34776511</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol. (2014) 26:54&#x2013;74. doi: 10.1016/j.smim.2014.01.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2014.01.001</ArticleId><ArticleId IdType="pubmed">24552665</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Hamid S, Cai J, Liu Q, Xu S, Zhang Z. Selenium deficiency-induced thioredoxin suppression and thioredoxin knock down disbalanced insulin responsiveness in chicken cardiomyocytes through PI3K/Akt pathway inhibition. Cell Signal. (2017) 38:192&#x2013;200. doi: 10.1016/j.cellsig.2017.07.012, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2017.07.012</ArticleId><ArticleId IdType="pubmed">28734787</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Gong Y, Cai J, Liu Q, Zhang Y, Zheng Y, et al. . Dysfunction of thioredoxin triggers inflammation through activation of autophagy in chicken cardiomyocytes. Biofactors. (2020) 46:579&#x2013;90. doi: 10.1002/biof.1625, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1625</ArticleId><ArticleId IdType="pubmed">32031748</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S, Zhang X, Xiao X, Luo W, Yang Z, Tang S, et al. . Exploring potential biomarkers and molecular mechanisms of ischemic cardiomyopathy and COVID-19 comorbidity based on bioinformatics and systems biology. Int J Mol Sci. (2023) 24:6511. doi: 10.3390/ijms24076511, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076511</ArticleId><ArticleId IdType="pmc">PMC10094917</ArticleId><ArticleId IdType="pubmed">37047484</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>